Marcel Rutten

Showing 1-6 of 6 articles

Interventions for valvular disease

Quantitative aortography assessment of aortic regurgitation

Modolo R, Chang C, Onuma Y, Schultz C, Tateishi H, Abdelghani M, Miyazaki Y, Aben J, Rutten M, Pighi M, El Bouziani A, van Mourik M, Lemos P, Wykrzykowska J, Brito F, Sahyoun C, Piazza N, Eltchaninoff H, Soliman O, Abdel-Wahab M, Van Mieghem N, de Winter R, Serruys P

October 9, 2020 | 10.4244/EIJ-D-19-00879

Coronary interventions

Validation of a three-dimensional quantitative coronary angiography-based software to calculate fractional flow reserve: the FAST study

Masdjedi K, Van Zandvoort L, Balbi M, Gijsen F, Ligthart J, Rutten M, Lemmert M, Wilschut J, Diletti R, de Jaegere P, Zijlstra F, Van Mieghem N, Daemen J

September 18, 2020 | 10.4244/EIJ-D-19-00466

Interventions for valvular disease

Videodensitometric quantification of paravalvular regurgitation of a transcatheter aortic valve: in vitro validation

Abdelghani M, Miyazaki Y, de Boer E, Aben J, van Sloun M, Suchecki T, van 't Veer M, Soliman O, Onuma Y, de Winter R, Tonino P, van de Vosse F, Rutten M, Serruys P

January 19, 2018 | 10.4244/EIJ-D-17-00595

A novel synchronised diastolic injection method to reduce contrast volume during aortography for aortic regurgitation assessment: in vitro experiment of a transcatheter heart valve model

Miyazaki Y, Abdelghani M, de Boer E, Aben J, van Sloun M, Suchecki T, van 't Veer M, Collet C, Asano T, Katagiri Y, Tenekecioglu E, Soliman O, Onuma Y, de Winter R, Tonino P, van de Vosse F, Rutten M, Serruys P

December 20, 2017 | 10.4244/EIJ-D-17-00355

Coronary interventions

Novel monorail infusion catheter for volumetric coronary blood flow measurement in humans: in vitro validation

van 't Veer M, Adjedj J, Wijnbergen I, Toth G, Rutten M, Barbato E, Van Nunen L, Pijls N, De Bruyne B

August 20, 2016 | 10.4244/EIJV12I6A114

Intra-aortic balloon counterpulsation reduces mortality in large anterior myocardial infarction complicated by persistent ischaemia: a CRISP-AMI substudy

Van Nunen L, van 't Veer M, Schampaert S, Rutten M, van de Vosse F, Patel M, Pijls N

July 20, 2015 | 10.4244/EIJY14M09_10

1

Latest news

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

October 19, 2021

My Stroke Story

October 20, 2021

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.

October 15, 2021

Valvular disease